CALF BLOOD GEMODIALIZAT REDUCES NEUROTOXIC EFFECT OF HYDROGEN PEROXIDE ON HUMAN NEUROBLASTOMA CELLS

Cover Page


Cite item

Full Text

Abstract

Objective: Our aim was to study the effect of calf blood gemodializat  on apoptosis and intracellular signaling pathways of neuroblastoma cells SK-N-SH human. Methods: Apoptosis was recorded by fluorescent microscopy using Hoechst 33342. Necrosis cells was monitored by propidium iodide. The fluorescence of the cells was recorded on a fluorescence inverted microscope Keyence BZ8100 (Japan). Formation of reactive oxygen species (ROS) in the cells of SK-N-SH was determined using nitroblue tetrazolium by absorbance at 620 nm on a plate reader «Uniplan». Results: When adding hydrogen peroxide to the background of the calf blood gemodializat been decreasing apoptosis of these cells with 43 to 17% relative to apoptosis in the presence of a hydrogen peroxide. Under these conditions, the calf blood gemodializat  significantly reduced ROS formation in human neuroblastoma cells SK-N-SH by the action of hydrogen peroxide. In these cells, we investigated the influence of calf blood gemodializat  on apoptosis and intracellular signaling pathway involving mitogen-activated protein kinase (p38MAPK), extracellular regulatory kinase (ERK), phosphatidylinositol 3-kinase (PI-3K) and-Jun-N-terminal kinase (JNK) using their selective inhibitors. Conclusion: It was shown that the mechanism of the protective effect of calf blood gemodializat   against peroxide-induced apoptosis in SK-N-SH dominant role is played by p38 MAPK and PI-3K.

 

About the authors

M. M. Yurinskaya

Sechenov First Moscow State Medical University, Moscow, Russian Federation
Institute of Cell Biophysics, Moscow Region, Russian Federation

Author for correspondence.
Email: marinayurin@mail.ru
кандидат биологических наук, старший научный сотрудник лаборатории экстре- мальных состояний НИЦ Первого МГМУ им. И.М. Сеченова, ведущий научный сотрудник Института биофизики клетки РАН Адрес: 142290, Московская обл., Пущино, ул.Институтская, д. 3, тел.: +7 (4967) 73-26-83 Russian Federation

M. G. Vinokurov

Sechenov First Moscow State Medical University, Moscow, Russian Federation
Institute of Cell Biophysics, Moscow Region, Russian Federation

Email: mgvinokurov@rambler.ru
доктор биологических наук, главный научный сотрудник лаборатории экстре- мальных состояний НИЦ Первого МГМУ им. И.М. Сеченова, заведующий лабораторией регуляции апоптоза Института биофизики клетки РАН Адрес: 142290, Московская обл., Пущино, ул.Институтская, д. 3, тел.: +7 (4967) 73-26-83 Russian Federation

E. I. Astashkin

Sechenov First Moscow State Medical University, Moscow, Russian Federation

Email: 287ast@mail.ru
доктор биологических наук, профессор кафедры патологии, заведующий лабораторией экстремальных состояний НИЦ Первого МГМУ им. И.М. Сеченова Адрес: 119992, Москва, ул. Трубецкая д. 8, стр. 1, тел.: +7 (495) 622-96-01

S. V. Grachev

Sechenov First Moscow State Medical University, Moscow, Russian Federation

Email: grachevscience@gmail.com
доктор медицинских наук, академик РАН, заведующий кафедрой патологии Первого МГМУ им. И.М. Сеченова Адрес: 119992, Москва, ул. Трубецкая д. 8, стр. 1, тел.: +7 (499) 248-31-22

N. S. Orekhova

Sechenov First Moscow State Medical University, Moscow, Russian Federation

Email: 287ast@mail.ru
кандидат медицинских наук, старший научный сотрудник лаборатории экстре- мальных состояний НИЦ Первого МГМУ им. И.М. Сеченова Адрес: 119992, Москва, ул. Трубецкая д. 8, стр. 1, тел.: +7 (495) 622-96-01 Russian Federation

A. N. Novikova

Sechenov First Moscow State Medical University, Moscow, Russian Federation

Email: 287ast@mail.ru
лаборант-исследователь лаборатории экстремальных состояний НИЦ Первого МГМУ им. И.М. Сеченова Адрес:119992, Москва, ул. Трубецкая д. 8, стр. 1, тел.: +7 (495) 622-96-01 Russian Federation

I. N. Sokolova

Sechenov First Moscow State Medical University, Moscow, Russian Federation

Email: 287ast@mail.ru
кандидат медицинских наук, ведущий научный сотрудник лаборатории функцио- нальных методов исследования и рациональной фармакотерапии сердечно-сосудистых заболеваний НИЦ Первого МГМУ им. И.М. Сеченова Адрес: 119992, Москва, ул. Трубецкая д. 8, стр. 1, тел.: +7 (499) 972-96-12 Russian Federation

References

  1. Buchmayer F., Pleiner J., Elmlinger M.W., Lauer G., Nell G., Sitte H.H. Actovegin: a biological drug for more than 5 decades. Wien. Med. Wochenschr. 2011; 161 (3–4): 80–88.
  2. Saeidnia S., Abdollahi M. Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicol. Appl. Pharmacol. 2013; 273 (3): 442–455.
  3. Neumann J., Sauerzweig S., Rönicke R., Gunzer F., Dinkel K., Ullrich O., Gunzer M., Reymann K.G. Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J. Neurosci. 2008; 28 (23): 5965–5975.
  4. Асташкин Е.И., Глезер М.Г., Винокуров М.Г., Егорова Н.Д., Орехова Н.С., Новикова А.Н., Грачев С.В., Юринская М.Н., Соболев К.Э. Актовегин снижает уровень радикалов кислорода в образцах цельной крови пациентов с сердечной недостаточностью и подавляет развитие некроза перевиваемых нейронов человека линии SK-N-SH. Доклады Академии наук. 2013; 448 (2): 232–235.
  5. Butterfield D.A., Swomley A.M., Sultana R. Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid. Redox Signal. 2013; 19 (8): 823–835.
  6. Elmlinger M.W., Kriebel M., Ziegler D. Neuroprotective and anti-oxidative effects of the hemodialysate actovegin on primary rat neurons in vitro. Neuromolec. Med. 2011; 13 (4): 266–274.
  7. Cui W., Li W., Zhao Y., Mak S., Gao Y., Luo J., Zhang H., Liu Y., Carlier P.R., Rong J., Han Y. Preventing H2O2-induced apoptosis in cerebellar granule neurons by regulating the VEGFR-2/Akt signaling pathway using a novel dimeric antiacetylcholinesterase bis(12)-hupyridone. Brain Res. 2011; 1394: 14–23.
  8. Zhao Z.Y., Luan P., Huang S.X., Xiao S.H., Zhao J., Zhang B., Gu B.B., Pi R.B., Liu J. Edaravone protects HT22 neurons from H2O2-induced apoptosis by inhibiting the MAPK signaling pathway. CNS Neuroscience & Ther. 2013; 19 (3): 163–169.
  9. Hyslop P.A., Zhang Z., Pearson D.V., Phebus L.A. Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat: correlation with the cytotoxic potential of H2O2 in vitro. Brain Res. 1995; 671 (2): 181–186.
  10. Peng Y., Hu Y., Feng N., Wang L., Wang X. L-3-n-butyl-phthalide alleviates hydrogen peroxide-induced apoptosis by PKC pathway in human neuroblastoma SK-N-SH cells. Naunyn. Schmiedebergs Arch. Pharmacol. 2011; 383 (1): 91–99.
  11. Wang X., Hu D., Zhang L., Lian G., Zhao S., Wang C., Yin J., Wu C., Yang J. Gomisin A inhibits lipopolysaccharide-induced inflammatory responses in N9 microglia via blocking the NF-kB/ MAPKs pathway. Food Chem. Toxicol. 2014; 63: 119–127.
  12. Ezoulin M.J., Ombetta J.E., Dutertre-Catella H., Warnet J.M., Massikot F. Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells. Neurotoxicology. 2008; 29 (2): 270–277.
  13. Jovanović Z. Mechanisms of neurodegeneration in Alzheimer’s disease. Med. Pregl. 2012; 65 (7–8): 301–307.
  14. Kwon S.H., Hong S.I., Jung Y.H., Kim M.J., Kim S.Y., Kim H.C., Lee S.Y., Jang C.G. Lonicera japonica THUNB. Protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-kB in SH-SY5Y cells. Food Chem. Toxicol. 2012; 50 (3–4): 797–807.
  15. Filomeni G., Piccirillo S., Rotilio G., Ciriolo M.R. p38(MAPK) and ERK1/2 dictate cell death/survival response to different pro-oxidant stimuli via p53 and Nrf2 in neuroblastoma cells SH-SY5Y. Biochem. Pharmacol. 2012; 83 (10): 1349–1357.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 1970 "Paediatrician" Publishers LLC



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies